FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912504528> ?p ?o ?g. }

• W2912504528 endingPage "303" @default.
• W2912504528 startingPage "297" @default.
• W2912504528 abstract "UGT2B17 gene deletion (UGT2B17*2) has been reported to affect bone health as well as the pharmacokinetics of aromatase inhibitor (AI) drugs such as exemestane. The goal of this study was to assess associations between UGT2B17 gene deletion and bone health prior to and after 24 months of AI treatment in postmenopausal women with hormone receptor positive (HR+) breast cancer. Bone health in women with HR+ breast cancer enrolled on the prospective randomized Exemestane and Letrozole Pharmacogenetics (ELPh) trial was determined by measuring bone turnover markers (BTM) and bone mineral density (BMD) pre-treatment and after 3 BTM and 24 BMD months of treatment with either the steroidal AI exemestane or the nonsteroidal AI letrozole. DNA samples were genotyped for UGT2B17*2. Of the 455 subjects included in the analyses, 244 (53.6%) carried at least one copy of UGT2B17*2. UGT2B17*2 was associated with lower pre-treatment BMD at the hip (P = 0.01) and spine (P = 0.0076). Letrozole treatment was associated with a greater decrease in BMD of the hip (P = 0.03) and spine (P = 0.03) than exemestane. UGT2B17 genotype was not associated with changes in BMD from 24 months of AI treatment, though in UGT2B17*2 homozygous patients, there was a trend toward greater decreases in BMD of the spine from treatment with letrozole compared with exemestane (P = 0.05). UGT2B17*2 may be associated with lower baseline BMD in women with HR+ breast cancer. Exemestane is less detrimental to bone health than letrozole in postmenopausal women treated with AI, and this effect may be confined to patients carrying UGT2B17*2, though this finding requires independent validation." @default.
• W2912504528 created "2019-02-21" @default.
• W2912504528 creator A5013320930 @default.
• W2912504528 creator A5043607190 @default.
• W2912504528 creator A5052071953 @default.
• W2912504528 creator A5056530735 @default.
• W2912504528 creator A5062446153 @default.
• W2912504528 creator A5063192858 @default.
• W2912504528 creator A5067053763 @default.
• W2912504528 creator A5067364668 @default.
• W2912504528 creator A5069748055 @default.
• W2912504528 creator A5075359631 @default.
• W2912504528 creator A5077394110 @default.
• W2912504528 creator A5083348030 @default.
• W2912504528 date "2019-02-12" @default.
• W2912504528 modified "2023-10-16" @default.
• W2912504528 title "Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion" @default.
• W2912504528 cites W1971400130 @default.
• W2912504528 cites W1972166009 @default.
• W2912504528 cites W1976694517 @default.
• W2912504528 cites W1980617781 @default.
• W2912504528 cites W1984522168 @default.
• W2912504528 cites W2018888053 @default.
• W2912504528 cites W2019210398 @default.
• W2912504528 cites W2020830322 @default.
• W2912504528 cites W2049553406 @default.
• W2912504528 cites W2050401007 @default.
• W2912504528 cites W2053551038 @default.
• W2912504528 cites W2073428316 @default.
• W2912504528 cites W2091496356 @default.
• W2912504528 cites W2111981448 @default.
• W2912504528 cites W2148378495 @default.
• W2912504528 cites W2162504881 @default.
• W2912504528 cites W2163873353 @default.
• W2912504528 cites W2167238270 @default.
• W2912504528 cites W2168772783 @default.
• W2912504528 cites W2175184309 @default.
• W2912504528 cites W2189611946 @default.
• W2912504528 cites W2601601396 @default.
• W2912504528 cites W2608008235 @default.
• W2912504528 doi "https://doi.org/10.1007/s10549-019-05158-3" @default.
• W2912504528 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6534458" @default.
• W2912504528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30747308" @default.
• W2912504528 hasPublicationYear "2019" @default.
• W2912504528 type Work @default.
• W2912504528 sameAs 2912504528 @default.
• W2912504528 citedByCount "3" @default.
• W2912504528 countsByYear W29125045282020 @default.
• W2912504528 countsByYear W29125045282021 @default.
• W2912504528 crossrefType "journal-article" @default.
• W2912504528 hasAuthorship W2912504528A5013320930 @default.
• W2912504528 hasAuthorship W2912504528A5043607190 @default.
• W2912504528 hasAuthorship W2912504528A5052071953 @default.
• W2912504528 hasAuthorship W2912504528A5056530735 @default.
• W2912504528 hasAuthorship W2912504528A5062446153 @default.
• W2912504528 hasAuthorship W2912504528A5063192858 @default.
• W2912504528 hasAuthorship W2912504528A5067053763 @default.
• W2912504528 hasAuthorship W2912504528A5067364668 @default.
• W2912504528 hasAuthorship W2912504528A5069748055 @default.
• W2912504528 hasAuthorship W2912504528A5075359631 @default.
• W2912504528 hasAuthorship W2912504528A5077394110 @default.
• W2912504528 hasAuthorship W2912504528A5083348030 @default.
• W2912504528 hasBestOaLocation W29125045282 @default.
• W2912504528 hasConcept C104317684 @default.
• W2912504528 hasConcept C121608353 @default.
• W2912504528 hasConcept C126322002 @default.
• W2912504528 hasConcept C134018914 @default.
• W2912504528 hasConcept C135763542 @default.
• W2912504528 hasConcept C143998085 @default.
• W2912504528 hasConcept C170033053 @default.
• W2912504528 hasConcept C2775860665 @default.
• W2912504528 hasConcept C2776166826 @default.
• W2912504528 hasConcept C2776541429 @default.
• W2912504528 hasConcept C2776886416 @default.
• W2912504528 hasConcept C2778504769 @default.
• W2912504528 hasConcept C2778812593 @default.
• W2912504528 hasConcept C530470458 @default.
• W2912504528 hasConcept C55493867 @default.
• W2912504528 hasConcept C55775858 @default.
• W2912504528 hasConcept C71924100 @default.
• W2912504528 hasConcept C86803240 @default.
• W2912504528 hasConceptScore W2912504528C104317684 @default.
• W2912504528 hasConceptScore W2912504528C121608353 @default.
• W2912504528 hasConceptScore W2912504528C126322002 @default.
• W2912504528 hasConceptScore W2912504528C134018914 @default.
• W2912504528 hasConceptScore W2912504528C135763542 @default.
• W2912504528 hasConceptScore W2912504528C143998085 @default.
• W2912504528 hasConceptScore W2912504528C170033053 @default.
• W2912504528 hasConceptScore W2912504528C2775860665 @default.
• W2912504528 hasConceptScore W2912504528C2776166826 @default.
• W2912504528 hasConceptScore W2912504528C2776541429 @default.
• W2912504528 hasConceptScore W2912504528C2776886416 @default.
• W2912504528 hasConceptScore W2912504528C2778504769 @default.
• W2912504528 hasConceptScore W2912504528C2778812593 @default.
• W2912504528 hasConceptScore W2912504528C530470458 @default.
• W2912504528 hasConceptScore W2912504528C55493867 @default.
• W2912504528 hasConceptScore W2912504528C55775858 @default.
• W2912504528 hasConceptScore W2912504528C71924100 @default.

• next